Barazanar ƙwayoyin cuta da yawa na numfashi a cikin hunturu
Matakan rage yaduwar SARS-CoV-2 suma sun yi tasiri wajen rage yaduwar wasu ƙwayoyin cuta na numfashi. Yayin da ƙasashe da yawa ke rage amfani da irin waɗannan matakan, SARS-CoV-2 zai yaɗu tare da wasu ƙwayoyin cuta na numfashi, wanda ke ƙara yiwuwar kamuwa da cututtuka tare.
Masana sun yi hasashen cewa za a iya samun barkewar cutar sau uku a wannan hunturu saboda haɗuwar kololuwar mura (Mura) da kwayar cutar numfashi (RSV) tare da annobar kwayar cutar SARS-CoV-2. Adadin wadanda suka kamu da cutar mura da RSV a wannan shekarar ya riga ya fi na lokacin guda a shekarun baya. Sabbin nau'ikan kwayar cutar SARS-CoV-2 BA.4 da BA.5 sun sake ta'azzara annobar.
A taron "Ranar Mura ta Duniya ta 2022" da aka gudanar a ranar 1 ga Nuwamba, 2022, Zhong Nanshan, wani masanin kimiyya na Kwalejin Injiniya ta kasar Sin, ya yi cikakken nazari kan yanayin mura a gida da waje, sannan ya yi bincike da yanke hukunci kan halin da ake ciki a yanzu."Duniya har yanzu tana fuskantar barazanar barkewar annobar cutar SARS-CoV-2 da kuma annobar mura." Ya nuna cewa, "Musamman a wannan hunturu, har yanzu tana buƙatar ƙarfafa bincike kan batutuwan kimiyya na rigakafi da shawo kan mura."A bisa kididdigar da hukumar CDC ta Amurka ta fitar, adadin wadanda suka ziyarci asibiti domin kamuwa da cututtukan numfashi a Amurka ya karu sosai saboda hadewar mura da sabbin cututtukan zuciya.
Ƙara yawan gano RSV da ziyartar sashen gaggawa da ke da alaƙa da RSV da kuma zuwa asibiti a yankuna da dama na Amurka, inda wasu yankuna ke gab da fuskantar yanayi mafi girma. A halin yanzu, adadin waɗanda suka kamu da cutar RSV a Amurka ya kai kololuwar da ta fi kololuwa a cikin shekaru 25, wanda ya sa asibitocin yara suka cika, kuma an rufe wasu makarantu.
Annobar mura ta barke a Ostiraliya a watan Afrilun wannan shekarar kuma ta shafe kusan watanni 4. Ya zuwa ranar 25 ga Satumba, an samu mutane 224,565 da suka kamu da mura da dakin gwaje-gwaje suka tabbatar, wanda ya haifar da mutuwar mutane 305. Sabanin haka, a karkashin matakan rigakafin barkewar cutar SARS-CoV-2, za a samu kimanin mutane 21,000 da suka kamu da mura a Ostiraliya a shekarar 2020 da kuma kasa da 1,000 a shekarar 2021.
Rahoton mako-mako na 35 na Cibiyar Influenza ta China a shekarar 2022 ya nuna cewa adadin wadanda suka kamu da mura a lardunan arewa ya fi na wannan lokacin a shekarar 2019-2021 tsawon makonni 4 a jere, kuma yanayin da ake ciki a nan gaba zai fi tsanani. Ya zuwa tsakiyar watan Yuni, adadin wadanda suka kamu da mura da aka ruwaito a Guangzhou ya karu da sau 10.38 idan aka kwatanta da bara.
Sakamakon wani bincike na ƙasashe 11 da The Lancet Global Health ta fitar a watan Oktoba ya nuna cewa yawan mutanen da ke kamuwa da mura a yanzu ya karu da kashi 60% idan aka kwatanta da kafin annobar. Haka kuma ya yi hasashen cewa kololuwar yawan mura a shekarar 2022 zai karu da sau 1-5, kuma girman annobar zai karu da sau 1-4.
An kwantar da manya 212,466 da suka kamu da cutar SARS-CoV-2 a asibiti. An yi gwajin kamuwa da cutar numfashi ga marasa lafiya 6,965 da ke dauke da cutar SARS-CoV-2. An gano kamuwa da cutar tare da kwayar cutar a cikin marasa lafiya 583 (8·4%): marasa lafiya 227 suna dauke da kwayar cutar mura, marasa lafiya 220 suna dauke da kwayar cutar numfashi mai kama da kwayar cutar, kuma marasa lafiya 136 suna dauke da kwayar cutar adenovirus.
An danganta kamuwa da ƙwayoyin cuta na mura da ƙaruwar damar samun iska mai guba idan aka kwatanta da SARS-CoV-2 mono-infection. Cututtukan SARS-CoV-2 tare da ƙwayoyin cuta na mura da adenoviruses kowannensu yana da alaƙa da ƙaruwar damar mutuwa. OR don samun iska mai guba a cikin kamuwa da mura tare da kamuwa da mura shine 4.14 (95% CI 2.00-8.49, p=0.0001). OR don mace-macen da ke cikin asibiti a cikin marasa lafiya da ke kamuwa da mura tare shine 2.35 (95% CI 1.07-5.12, p=0.031). OR don mace-macen da ke cikin asibiti a cikin marasa lafiya da ke kamuwa da adenovirus tare shine 1.6 (95% CI 1.03-2.44, p=0.033).
Sakamakon wannan binciken ya nuna mana a sarari cewa kamuwa da cuta tare da kwayar cutar SARS-CoV-2 da kwayar cutar mura yanayi ne mai matuƙar haɗari.
Kafin barkewar cutar SARS-CoV-2, alamun cututtukan numfashi daban-daban sun yi kama da juna, amma hanyoyin magance su sun bambanta. Idan marasa lafiya ba su dogara da gwaje-gwaje da yawa ba, maganin ƙwayoyin cutar numfashi zai ƙara rikitarwa, kuma zai ɓatar da albarkatun asibiti cikin sauƙi a lokutan da ke da yawan kamuwa da cuta. Saboda haka, gwaje-gwajen haɗin gwiwa da yawa suna taka muhimmiyar rawa a cikin ganewar asibiti, kuma likitoci suna iya ba da ganewar cututtuka daban-daban a cikin marasa lafiya da ke da alamun numfashi ta hanyar samfurin swab guda ɗaya.
Maganin Gano Hadin Gaggawa Mai Yawa Na Macro & Micro-Gwajin SARS-CoV-2
Gwajin Macro & Micro-Test yana da dandamali na fasaha kamar su fluorescent quantitative PCR, isothermal amplification, rigakafi, da POCT na kwayoyin halitta, kuma yana ba da nau'ikan samfuran gano haɗin gwiwa na numfashi na SARS-CoV-2. Duk samfuran sun sami takardar shaidar EU CE, tare da kyakkyawan aikin samfura da ƙwarewar mai amfani mai kyau.
1. Kayan RT-PCR mai haske a ainihin lokaci don gano nau'ikan cututtukan numfashi guda shida
Sarrafa Cikin Gida: A sa ido sosai kan tsarin gwaji don tabbatar da ingancin gwaje-gwajen.
Ingantaccen Inganci: Multiplex real-time PCR yana gano takamaiman abubuwan da aka keɓance ga SARS-CoV-2, Mura A, Mura B, Adenovirus, Mycoplasma pneumoniae, da kuma cutar Respiratory syncytial.
Babban hankali: Kwafi 300/mL don SARS-CoV-2, Kwafi 500/mL don kwayar cutar mura A, Kwafi 500/mL don kwayar cutar mura B, Kwafi 500/mL don kwayar cutar syncytial ta numfashi, Kwafi 500/mL don cutar mycoplasma pneumoniae, da Kwafi 500/mL don adenovirus.
2. Kayan Gano Kwayoyin Cutar SARS-CoV-2/Influenza A /Influenza B Nucleic Acid (Fluorescence PCR)
Sarrafa Cikin Gida: A sa ido sosai kan tsarin gwaji don tabbatar da ingancin gwaje-gwajen.
Ingantaccen Inganci: Multiplex real-time PCR yana gano takamaiman abubuwan da aka keɓance ga SARS-CoV-2, Mura A da Mura B.
Babban hankali: Kwafi 300/mL na SARS-CoV-2,500 Kwafi/mL na lFV A da 500 Kwafi/mL na lFV B.
3. Kayan Gano Maganin Cutar SARS-CoV-2, Mura A da Influenza B (Immunochromatography)
Mai Sauƙin Amfani
Zafin Ɗaki Sufuri & Ajiyewa a 4-30°℃
Babban hankali da takamaiman bayani
| Sunan Samfuri | Ƙayyadewa |
| Kayan RT-PCR mai haske na ainihin lokaci don gano nau'ikan cututtukan numfashi guda shida | Gwaje-gwaje 20/kayan aiki,Gwaje-gwaje 48/kayan aiki,Gwaje-gwaje 50/kayan aiki |
| Kayan Gano Kwayoyin Cutar Nucleic Acid Mai Haɗaka (Fluorescence PCR) na SARS-CoV-2/Influenza A/Influenza B | Gwaje-gwaje 48/kayan aiki,Gwaje-gwaje 50/kayan aiki |
| Kayan Gano Maganin Cutar SARS-CoV-2, Mura A da Influenza B (Immunochromatography) | 1 gwaji/kayan aiki,Gwaje-gwaje 20/kayan aiki |
Lokacin Saƙo: Disamba-09-2022